These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35893231)

  • 21. Downregulation of miRNA-29, -23 and -21 in urine of Duchenne muscular dystrophy patients.
    Catapano F; Domingos J; Perry M; Ricotti V; Phillips L; Servais L; Seferian A; Groot I; Krom YD; Niks EH; Verschuuren JJ; Straub V; Voit T; Morgan J; Muntoni F
    Epigenomics; 2018 Jul; 10(7):875-889. PubMed ID: 29564913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptomic analysis of dystrophin RNAi knockdown reveals a central role for dystrophin in muscle differentiation and contractile apparatus organization.
    Ghahramani Seno MM; Trollet C; Athanasopoulos T; Graham IR; Hu P; Dickson G
    BMC Genomics; 2010 Jun; 11():345. PubMed ID: 20515474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Causes of clinical variability in Duchenne and Becker muscular dystrophies and implications for exon skipping therapies.
    Hoffman EP
    Acta Myol; 2020 Dec; 39(4):179-186. PubMed ID: 33458572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-Administration of Simvastatin Does Not Potentiate the Benefit of Gene Therapy in the mdx Mouse Model for Duchenne Muscular Dystrophy.
    Bourg N; Vu Hong A; Lostal W; Jaber A; Guerchet N; Tanniou G; Bordier F; Bertil-Froidevaux E; Georger C; Daniele N; Richard I; Israeli D
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human muscle gene expression responses to endurance training provide a novel perspective on Duchenne muscular dystrophy.
    Timmons JA; Larsson O; Jansson E; Fischer H; Gustafsson T; Greenhaff PL; Ridden J; Rachman J; Peyrard-Janvid M; Wahlestedt C; Sundberg CJ
    FASEB J; 2005 May; 19(7):750-60. PubMed ID: 15857889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A review on muscle-specific microRNAs as the biomarker for Duchenne muscular dystrophy].
    Meng Q; Lan D
    Zhongguo Dang Dai Er Ke Za Zhi; 2019 Nov; 21(11):1148-1152. PubMed ID: 31753100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.
    Duarte FV; Palmeira CM; Rolo AP
    Adv Exp Med Biol; 2015; 888():123-54. PubMed ID: 26663182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytoplasmic HDAC4 regulates the membrane repair mechanism in Duchenne muscular dystrophy.
    Renzini A; Marroncelli N; Cavioli G; Di Francescantonio S; Forcina L; Lambridis A; Di Giorgio E; Valente S; Mai A; Brancolini C; Giampietri C; Magenta A; De Santa F; Adamo S; Coletti D; Moresi V
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1339-1359. PubMed ID: 35170869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iron overload and impaired iron handling contribute to the dystrophic pathology in models of Duchenne muscular dystrophy.
    Alves FM; Kysenius K; Caldow MK; Hardee JP; Chung JD; Trieu J; Hare DJ; Crouch PJ; Ayton S; Bush AI; Lynch GS; Koopman R
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1541-1553. PubMed ID: 35249268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High prevalence of plasma lipid abnormalities in human and canine Duchenne and Becker muscular dystrophies depicts a new type of primary genetic dyslipidemia.
    White Z; Hakim CH; Theret M; Yang NN; Rossi F; Cox D; Francis GA; Straub V; Selby K; Panagiotopoulos C; Duan D; Bernatchez P
    J Clin Lipidol; 2020; 14(4):459-469.e0. PubMed ID: 32593511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide Mechanosensitive MicroRNA (MechanomiR) Screen Uncovers Dysregulation of Their Regulatory Networks in the mdm Mouse Model of Muscular Dystrophy.
    Mohamed JS; Hajira A; Lopez MA; Boriek AM
    J Biol Chem; 2015 Oct; 290(41):24986-5011. PubMed ID: 26272747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinctive patterns of microRNA expression in primary muscular disorders.
    Eisenberg I; Eran A; Nishino I; Moggio M; Lamperti C; Amato AA; Lidov HG; Kang PB; North KN; Mitrani-Rosenbaum S; Flanigan KM; Neely LA; Whitney D; Beggs AH; Kohane IS; Kunkel LM
    Proc Natl Acad Sci U S A; 2007 Oct; 104(43):17016-21. PubMed ID: 17942673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive analysis of the expression profile of circRNAs and their predicted protein-coding ability in the muscle of mdx mice.
    Song Z; Liu Y; Fang X; Xie M; Ma Z; Zhong Z; Feng X; Zhang W
    Funct Integr Genomics; 2020 May; 20(3):397-407. PubMed ID: 31736012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of DMD pathology by an ankyrin-encoded miRNA.
    Alexander MS; Casar JC; Motohashi N; Myers JA; Eisenberg I; Gonzalez RT; Estrella EA; Kang PB; Kawahara G; Kunkel LM
    Skelet Muscle; 2011 Aug; 1():27. PubMed ID: 21824387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miRNA and Proteomic Dysregulation in Non-Small Cell Lung Cancer in Response to Cigarette Smoke.
    Babu N; Advani J; Solanki HS; Patel K; Jain A; Khan AA; Radhakrishnan A; Sahasrabuddhe NA; Mathur PP; Nair B; Keshava Prasad TS; Chang X; Sidransky D; Gowda H; Chatterjee A
    Microrna; 2018; 7(1):38-53. PubMed ID: 29299995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscle Weakness in Myositis: MicroRNA-Mediated Dystrophin Reduction in a Myositis Mouse Model and Human Muscle Biopsies.
    Kinder TB; Heier CR; Tully CB; Van der Muelen JH; Hoffman EP; Nagaraju K; Fiorillo AA
    Arthritis Rheumatol; 2020 Jul; 72(7):1170-1183. PubMed ID: 32009304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism.
    Al-Khalidi R; Panicucci C; Cox P; Chira N; Róg J; Young CNJ; McGeehan RE; Ambati K; Ambati J; Zabłocki K; Gazzerro E; Arkle S; Bruno C; Górecki DC
    Acta Neuropathol Commun; 2018 Apr; 6(1):27. PubMed ID: 29642926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying the hub genes for Duchenne muscular dystrophy and Becker muscular dystrophy by weighted correlation network analysis.
    Wang J; Fan Q; Yu T; Zhang Y
    BMC Genom Data; 2021 Dec; 22(1):57. PubMed ID: 34922439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNAs in Dystrophinopathy.
    Lee A; Moon J; Yu J; Kho C
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of qPCR Reference Genes Suitable for Normalizing Gene Expression in a Canine Model of Duchenne Muscular Dystrophy.
    Hildyard JCW; Taylor-Brown F; Massey C; Wells DJ; Piercy RJ
    J Neuromuscul Dis; 2018; 5(2):177-191. PubMed ID: 29614692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.